Enliven Therapeutics Inc (ELVN) USD0.001

Sell:$27.78Buy:$27.82Price decreased$1.06 (3.68%)

NASDAQ:Price decreased0.93%
Market closed |
Prices delayed by at least 15 minutes
Sell:$27.78
Buy:$27.82
Change:Price decreased$1.06 (3.68%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$27.78
Buy:$27.82
Change:Price decreased$1.06 (3.68%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 March 2026
Helen Louise CollinsOther Level A
Sell
Option/Award related
10,129$30.19$305,826.9225,000
9 March 2026
Helen Louise CollinsOther Level A
Sell
Option/Award related
29,871$30.02$896,811.0625,000
6 March 2026
Benjamin (Ben) HohlCFO
Sell
Regular sell transaction (market)
10,000$29.58$295,839.0051,000
17 February 2026
Helen Louise CollinsOther Level A
Sell
Option/Award related
45,000$26.17$1,177,861.5025,000
17 February 2026
Richard A. (Rich) HeymanChairman of the Board
Sell
Regular sell transaction (market)
1,230$26.18$32,196.3622,647
6 February 2026
Joseph P (Joe) LyssikatosPresident
Sell
Regular sell transaction (market)
5,000$29.04$145,219.00740,188
20 January 2026
Joseph P (Joe) LyssikatosPresident
Sell
Regular sell transaction (market)
5,491$26.37$144,814.14759,697
20 January 2026
Joseph P (Joe) LyssikatosPresident
Sell
Regular sell transaction (market)
14,509$26.90$390,284.85745,188
20 January 2026
Richard A. (Rich) HeymanChairman of the Board
Sell
Regular sell transaction (market)
512$26.46$13,547.1124,595
20 January 2026
Richard A. (Rich) HeymanChairman of the Board
Sell
Regular sell transaction (market)
718$26.96$19,354.4123,877

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
9 January 2026
Joseph P (Joe) LyssikatosPresident
Sell
Regular sell transaction (market)
50,000$29.13$1,456,715.00765,188
9 January 2026
Anish PatelCOO
Sell
Regular sell transaction (market)
48,057$27.98$1,344,836.70215,254
17 February 2026
Helen Louise CollinsOther Level A
Sell
Option/Award related
45,000$26.17$1,177,861.5025,000
9 January 2026
Joseph P (Joe) LyssikatosPresident
Sell
Regular sell transaction (market)
41,198$24.90$1,025,863.16815,188
9 March 2026
Helen Louise CollinsOther Level A
Sell
Option/Award related
29,871$30.02$896,811.0625,000

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.